{"id":"https://openalex.org/W1993760950","doi":"https://doi.org/10.1097/00007691-198512000-00004","title":"Serum Concentrations of Valproic Acid","display_name":"Serum Concentrations of Valproic Acid","publication_year":1985,"publication_date":"1985-12-01","ids":{"openalex":"https://openalex.org/W1993760950","doi":"https://doi.org/10.1097/00007691-198512000-00004","mag":"1993760950","pmid":"https://pubmed.ncbi.nlm.nih.gov/3936236"},"language":"en","primary_location":{"id":"doi:10.1097/00007691-198512000-00004","doi":"https://doi.org/10.1097/00007691-198512000-00004","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00007691-198512000-00004","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"T. May","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268133","display_name":"Gesellschaft f\u00fcr Epilepsieforschung e.V.","ror":"https://ror.org/000ayt557","country_code":"DE","type":"nonprofit","lineage":["https://openalex.org/I4405268133"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"T. May","raw_affiliation_strings":["Department of Biochemistry, Gesellschaft f\u00fcr Epilepsieforschung, Bielefeld-Bethel, F.R.G"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry, Gesellschaft f\u00fcr Epilepsieforschung, Bielefeld-Bethel, F.R.G","institution_ids":["https://openalex.org/I4405268133"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113521331","display_name":"Bernhard Rambeck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268133","display_name":"Gesellschaft f\u00fcr Epilepsieforschung e.V.","ror":"https://ror.org/000ayt557","country_code":"DE","type":"nonprofit","lineage":["https://openalex.org/I4405268133"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"B. Rambeck","raw_affiliation_strings":["Department of Biochemistry, Gesellschaft f\u00fcr Epilepsieforschung, Bielefeld-Bethel, F.R.G"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry, Gesellschaft f\u00fcr Epilepsieforschung, Bielefeld-Bethel, F.R.G","institution_ids":["https://openalex.org/I4405268133"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405268133"],"apc_list":null,"apc_paid":null,"fwci":1.9414,"has_fulltext":false,"cited_by_count":60,"citation_normalized_percentile":{"value":0.83525191,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"7","issue":"4","first_page":"387","last_page":"390"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.47749999165534973,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.47749999165534973,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.33809998631477356,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.056299999356269836,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/valproic-acid","display_name":"valproic acid","score":0.9449999928474426},{"id":"https://openalex.org/keywords/serum-drug-levels","display_name":"serum drug concentration","score":0.8859999775886536},{"id":"https://openalex.org/keywords/dose-concentration-relationship","display_name":"dose-concentration relationship","score":0.7599999904632568},{"id":"https://openalex.org/keywords/nonlinear-pharmacokinetics","display_name":"nonlinear pharmacokinetics","score":0.8669999837875366},{"id":"https://openalex.org/keywords/concomitant-medications","display_name":"concomitant medications","score":0.7020000219345093},{"id":"https://openalex.org/keywords/phenytoin","display_name":"phenytoin","score":0.8429999947547913},{"id":"https://openalex.org/keywords/carbamazepine","display_name":"carbamazepine","score":0.9620000123977661},{"id":"https://openalex.org/keywords/phenobarbital","display_name":"phenobarbital","score":0.9980000257492065},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.7710000276565552},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.9229999780654907},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.9120000004768372}],"concepts":[{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.9598615169525146},{"id":"https://openalex.org/C2778793413","wikidata":"https://www.wikidata.org/wiki/Q407241","display_name":"Phenobarbital","level":2,"score":0.8721746206283569},{"id":"https://openalex.org/C2778337148","wikidata":"https://www.wikidata.org/wiki/Q410400","display_name":"Phenytoin","level":3,"score":0.8496822118759155},{"id":"https://openalex.org/C2777172819","wikidata":"https://www.wikidata.org/wiki/Q240642","display_name":"Valproic Acid","level":3,"score":0.7562828660011292},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.6708614230155945},{"id":"https://openalex.org/C3020081911","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Serum concentration","level":2,"score":0.6640490293502808},{"id":"https://openalex.org/C19720800","wikidata":"https://www.wikidata.org/wiki/Q7722","display_name":"Morning","level":2,"score":0.5624039173126221},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5365680456161499},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5069358944892883},{"id":"https://openalex.org/C3020079912","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma concentration","level":2,"score":0.4715096056461334},{"id":"https://openalex.org/C147583825","wikidata":"https://www.wikidata.org/wiki/Q620876","display_name":"Body weight","level":2,"score":0.46777763962745667},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45532089471817017},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41856300830841064},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33408260345458984},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.24538707733154297},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010634","descriptor_name":"Phenobarbital","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010672","descriptor_name":"Phenytoin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012737","descriptor_name":"Sex Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014635","descriptor_name":"Valproic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014635","descriptor_name":"Valproic Acid","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00007691-198512000-00004","doi":"https://doi.org/10.1097/00007691-198512000-00004","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00007691-198512000-00004","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},{"id":"pmid:3936236","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3936236","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic drug monitoring","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2031300985","https://openalex.org/W2361169346","https://openalex.org/W2022108024","https://openalex.org/W2362634673","https://openalex.org/W2615543963","https://openalex.org/W2802644563","https://openalex.org/W2142499984","https://openalex.org/W2017898520","https://openalex.org/W1984077414","https://openalex.org/W1982258592"],"abstract_inverted_index":{"The":[0,76,102],"influence":[1,71],"of":[2,25,38,46,66,82,105],"valproate":[3],"(VPA)":[4],"dose,":[5,56],"VPA":[6,26,43,74,83,106],"preparation":[7,67],"used,":[8],"comedication":[9],"(phenobarbital,":[10],"phenytoin,":[11],"carbamazepine)":[12],"and":[13,20,60,64,80],"factors":[14],"such":[15],"as":[16,86],"age,":[17],"weight,":[18,58],"height,":[19,63],"sex":[21],"on":[22,72],"the":[23,39,42,53,73,87,94,111],"concentration":[24,81,88,104],"in":[27,41,115],"serum":[28,103],"was":[29],"investigated.":[30],"Nonlinear":[31],"regression":[32],"analysis":[33],"showed":[34],"that":[35],"about":[36],"63%":[37],"variance":[40],"morning":[44],"concentrations":[45],"259":[47],"inpatients":[48],"could":[49],"be":[50],"explained":[51],"by":[52],"following":[54],"variables:":[55],"body":[57],"sex,":[59],"comedication.":[61],"Age,":[62],"kind":[65],"had":[68],"no":[69],"important":[70],"concentration.":[75],"relationship":[77],"between":[78],"dose":[79,95],"is":[84,107,113],"nonlinear,":[85],"does":[89],"not":[90],"increase":[91],"proportionally":[92],"with":[93,117],"but":[96],"increases":[97],"to":[98],"a":[99],"lesser":[100],"extent.":[101],"clearly":[108],"lower":[109],"when":[110,126],"drug":[112],"given":[114,127],"combination":[116],"phenytoin":[118],"(49.5%),":[119],"carbamazepine":[120],"(66.2%),":[121],"or":[122],"phenobarbital":[123],"(76.3%)":[124],"than":[125],"alone":[128],"(100%).":[129]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}